Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer

Nucleic Acids Research

Volumn 41, Issue 14, 2013, Pages 6857-6869

  Cruickshanks, Hazel A ^a,b   Vafadar Isfahani, Natasha ^a   Dunican, Donncha S ^b   Lee, Andy ^a   Sproul, Duncan ^b,c   Lund, Jonathan N ^a   Meehan, Richard R ^b,c   Tufarelli, Cristina ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; HISTONE;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CHIMERA; CHROMATIN; COLON CANCER; CONTROLLED STUDY; DNA MODIFICATION; EMBRYONIC STEM CELL; EPIGENETICS; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RETROPOSON; TFPI 2 GENE; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DOWN-REGULATION; EMBRYONIC STEM CELLS; FEMALE; GENE SILENCING; GENES, TUMOR SUPPRESSOR; GLYCOPROTEINS; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MCF-7 CELLS; MICE; RNA, ANTISENSE;

EID: 84881484687     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt438     Document Type: Article

References (65)

1. Sharma S., Kelly T.K. and Jones P.A. (2010) Epigenetics in cancer. Carcinogenesis, 31, 27-36
2. Hammerman P.S., Hayes D.N., Wilkerson M.D., Schultz N., Bose R., Chu A., Collisson E.A., Cope L., Creighton C.J., Getz G. et al. (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature, 489, 519-525
3. Feinberg A.P. and Tycko B. (2004) The history of cancer epigenetics. Nat. Rev., 4, 143-153
4. Hon G.C., Hawkins R.D., Caballero O.L., Lo C., Lister R., Pelizzola M., Valsesia A., Ye Z., Kuan S., Edsall L.E. et al. (2012) Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res., 22, 246-258
5. Figueroa M.E., Abdel-Wahab O., Lu C., Ward P.S., Patel J., Shih A., Li Y., Bhagwat N., Vasanthakumar A., Fernandez H.F. et al. (2010) Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell, 18, 553-567
6. Sproul D., Kitchen R.R., Nestor C.E., Dixon J.M., Sims A.H., Harrison D.J., Ramsahoye B.H. and Meehan R.R. (2012) Tissue of origin determines cancer-Associated CpG island promoter hypermethylation patterns. Genome Biol., 13, R84
7. Sproul D., Nestor C., Culley J., Dickson J.H., Dixon J.M., Harrison D.J., Meehan R.R., Sims A.H. and Ramsahoye B.H. (2011) Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc. Natl Acad. Sci. USA, 108, 4364-4369
8. Schulz W.A., Steinhoff C. and Florl A.R. (2006) Curr Top Microbiol Immunol, Vol. 310, pp. 211-250
9. Estecio M.R., Gharibyan V., Shen L., Ibrahim A.E., Doshi K., He R., Jelinek J., Yang A.S., Yan P.S., Huang T.H. et al. (2007) LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One, 2, e399
10. Eden A., Gaudet F., Waghmare A. and Jaenisch R. (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science, 300, 455
11. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., Leonhardt H. and Jaenisch R. (2003) Induction of tumors in mice by genomic hypomethylation. Science, 300, 489-492
12. Roman-Gomez J., Jimenez-Velasco A., Agirre X., Castillejo J.A., Navarro G., San Jose-Eneriz E., Garate L., Cordeu L., Cervantes F., Prosper F. et al. (2008) Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia. Leuk. Res., 32, 487-490
13. Gilbert N., Lutz-Prigge S. and Moran J.V. (2002) Genomic deletions created upon LINE-1 retrotransposition. Cell, 110, 315-325
14. Howard G., Eiges R., Gaudet F., Jaenisch R. and Eden A. (2008) Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene, 27, 404-408
15. Symer D.E., Connelly C., Szak S.T., Caputo E.M., Cost G.J., Parmigiani G. and Boeke J.D. (2002) Human l1 retrotransposition is associated with genetic instability in vivo. Cell, 110, 327-338
16. Iskow R.C., McCabe M.T., Mills R.E., Torene S., Pittard W.S., Neuwald A.F., Van Meir E.G., Vertino P.M. and Devine S.E. (2010) Natural mutagenesis of human genomes by endogenous retrotransposons. Cell, 141, 1253-1261
17. Solyom S., Ewing A.D., Rahrmann E.P., Doucet T.T., Nelson H.H., Burns M.B., Harris R.S., Sigmon D.F., Casella A., Erlanger B. et al. (2012) Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res., 22, 2328-2338
18. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W. et al. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860-921
19. Khan H., Smit A. and Boissinot S. (2006) Molecular evolution and tempo of amplification of human LINE-1 retrotransposons since the origin of primates. Genome Res., 16, 78-87
20. Faulkner G.J., Kimura Y., Daub C.O., Wani S., Plessy C., Irvine K.M., Schroder K., Cloonan N., Steptoe A.L., Lassmann T. et al. (2009) The regulated retrotransposon transcriptome of mammalian cells. Nat. Genet., 41, 563-571
21. Speek M. (2001) Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol. Cell Biol., 21, 1973-1985
22. Cruickshanks H.A. and Tufarelli C. (2009) Isolation of cancerspecific chimeric transcripts induced by hypomethylation of the LINE-1 antisense promoter. Genomics, 94, 397-406
23. Alves G., Tatro A. and Fanning T. (1996) Differential methylation of human LINE-1 retrotransposons in malignant cells. Gene, 176, 39-44
24. Chalitchagorn K., Shuangshoti S., Hourpai N., Kongruttanachok N., Tangkijvanich P., Thong-ngam D., Voravud N., Sriuranpong V. and Mutirangura A. (2004) Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene, 23, 8841-8846
25. Wilson A.S., Power B.E. and Molloy P.L. (2007) DNA hypomethylation and human diseases. Biochim. Biophys. Acta, 1775, 138-162
26. Conley A.B., Miller W.J. and Jordan I.K. (2008) Human cis natural antisense transcripts initiated by transposable elements. Trends Genet., 24, 53-56
27. Nigumann P., Redik K., Matlik K. and Speek M. (2002) Many human genes are transcribed from the antisense promoter of L1 retrotransposon. Genomics, 79, 628-634
28. Roman-Gomez J., Jimenez-Velasco A., Agirre X., Cervantes F., Sanchez J., Garate L., Barrios M., Castillejo J.A., Navarro G., Colomer D. et al. (2005) Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene, 24, 7213-7223
29. Weber B., Kimhi S., Howard G., Eden A. and Lyko F. (2010) Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription. Oncogene, 29, 5775-5784
30. Wolff E.M., Byun H.M., Han H.F., Sharma S., Nichols P.W., Siegmund K.D., Yang A.S., Jones P.A. and Liang G. (2010) Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet., 6, e1000917
31. Magistri M., Faghihi M.A., St Laurent G. III and Wahlestedt C. (2012) Regulation of chromatin structure by long noncoding RNAs: Focus on natural antisense transcripts. Trends Genet., 28, 389-396
32. Matzke M.A. and Birchler J.A. (2005) RNAi-mediated pathways in the nucleus. Nat. Rev. Genet., 6, 24-35
33. Taft R.J., Pang K.C., Mercer T.R., Dinger M. and Mattick J.S. (2010) Non-coding RNAs: Regulators of disease. J. Pathol., 220, 126-139
34. Tufarelli C., Stanley J.A., Garrick D., Sharpe J.A., Ayyub H., Wood W.G. and Higgs D.R. (2003) Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat. Genet., 34, 157-165
35. Yu W., Gius D., Onyango P., Muldoon-Jacobs K., Karp J., Feinberg A.P. and Cui H. (2008) Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature, 451, 202-206
36. Olek A., Oswald J. and Walter J. (1996) A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res., 24, 5064-5066
37. Bock C., Reither S., Mikeska T., Paulsen M., Walter J. and Lengauer T. (2005) BiQ analyzer: Visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics, 21, 4067-4068
38. Cereghini S. and Yaniv M. (1984) Assembly of transfected DNA into chromatin: Structural changes in the origin-promoterenhancer region upon replication. EMBO J., 3, 1243-1253
39. O'Neill L.P. and Turner B.M. (2003) Immunoprecipitation of native chromatin: NChIP. Methods (San Diego, Calif, 31, 76-82
40. Iino M., Foster D.C. and Kisiel W. (1998) Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. Arterioscler. Thromb. Vasc. Biol., 18, 40-46
41. Sierko E., Wojtukiewicz M.Z. and Kisiel W. (2007) The role of tissue factor pathway inhibitor-2 in cancer biology. Semin. Thromb. Hemost., 33, 653-659
42. Konduri S.D., Yanamandra N., Dinh D.H., Olivero W.C., Gujrati M., Foster D.C., Kisiel W. and Rao J.S. (2003) Physiological and chemical inducers of tissue factor pathway inhibitor-2 in human glioma cells. Int. J. Oncol., 22, 1277-1283
43. Sato N., Parker A.R., Fukushima N., Miyagi Y., Iacobuzio-Donahue C.A., Eshleman J.R. and Goggins M. (2005) Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene, 24, 850-858
44. Bolland D.J., Wood A.L., Johnston C.M., Bunting S.F., Morgan G., Chakalova L., Fraser P.J. and Corcoran A.E. (2004) Antisense intergenic transcription in V(D)J recombination. Nat. Immunol., 5, 630-637
45. Latos P.A., Stricker S.H., Steenpass L., Pauler F.M., Huang R., Senergin B.H., Regha K., Koerner M.V., Warczok K.E., Unger C. et al. (2009) An in vitro ES cell imprinting model shows that imprinted expression of the Igf2r gene arises from an allelespecific expression bias. Development, 136, 437-448
46. Kamei S., Kazama Y., Kuijper J.L., Foster D.C. and Kisiel W. (2001) Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene. Biochim. Biophys. Acta., 1517, 430-435
47. Barrow K.M., Perez-Campo F.M. and Ward C.M. (2006) Use of the cytomegalovirus promoter for transient and stable transgene expression in mouse embryonic stem cells. Methods Mol. Biol., 329, 283-294
48. Margueron R. and Reinberg D. (2011) The Polycomb complex PRC2 and its mark in life. Nature, 469, 343-349
49. Weber M., Hellmann I., Stadler M.B., Ramos L., Paabo S., Rebhan M. and Schubeler D. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet., 39, 457-466
50. Gullerova M. and Proudfoot N.J. (2012) Convergent transcription induces transcriptional gene silencing in fission yeast and mammalian cells. Nat. Struct. Mol. Biol., 19, 1193-1201
51. Latos P.A., Pauler F.M., Koerner M.V., Senergin H.B., Hudson Q.J., Stocsits R.R., Allhoff W., Stricker S.H., Klement R.M., Warczok K.E. et al. (2012) Airn transcriptional overlap, but not its lncRNA products, induces imprinted Igf2r silencing. Science, 338, 1469-1472
52. Kisiel W., Sprecher C.A. and Foster D.C. (1994) Evidence that a second human tissue factor pathway inhibitor (TFPI-2) and human placental protein 5 are equivalent. Blood, 84, 4384-4385
53. Sprecher C.A., Kisiel W., Mathewes S. and Foster D.C. (1994) Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc. Natl Acad. Sci. USA, 91, 3353-3357
54. Chand H.S., Du X., Ma D., Inzunza H.D., Kamei S., Foster D., Brodie S. and Kisiel W. (2004) The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice. Blood, 103, 1069-1077
55. Rao C.N., Segawa T., Navari J.R., Xu L., Srivastava S., Moul J.W. and Phillips B. (2003) Methylation of TFPI-2 gene is not the sole cause of its silencing. Int J Oncol, 22, 843-848
56. Ma S., Chan Y.P., Kwan P.S., Lee T.K., Yan M., Tang K.H., Ling M.T., Vielkind J.R., Guan X.Y. and Chan K.W. (2011) MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2. Cancer Res., 71, 583-592
57. Yap K.L., Li S., Munoz-Cabello A.M., Raguz S., Zeng L., Mujtaba S., Gil J., Walsh M.J. and Zhou M.M. (2010) Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell, 38, 662-674
58. Wong C.M., Ng Y.L., Lee J.M., Wong C.C., Cheung O.F., Chan C.Y., Tung E.K., Ching Y.P. and Ng I.O. (2007) Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology, 45, 1129-1138
59. Kaneda A., Tsukamoto T., Takamura-Enya T., Watanabe N., Kaminishi M., Sugimura T., Tatematsu M. and Ushijima T. (2004) Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci., 95, 58-64
60. Clark S.J. (2007) Action at a distance: Epigenetic silencing of large chromosomal regions in carcinogenesis. Hum. Mol. Gen., 16(Spec No 1), R88-R95
61. Weber B., Kimhi S., Howard G., Eden A. and Lyko F. (2010) Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription. Oncogene, 29, 5775-5784
62. Yoder J.A., Walsh C.P. and Bestor T.H. (1997) Cytosine methylation and the ecology of intragenomic parasites. Trends Genet., 13, 335-340
63. Beraldi R., Pittoggi C., Sciamanna I., Mattei E. and Spadafora C. (2006) Expression of LINE-1 retroposons is essential for murine preimplantation development. Mol. Reprod. Dev., 73, 279-287
64. Lu C., Meyers B.C. and Green P.J. (2007) Construction of small RNA cDNA libraries for deep sequencing. Methods, 43, 110-117
65. Pall G.S., Codony-Servat C., Byrne J., Ritchie L. and Hamilton A. (2007) Carbodiimide-mediated cross-linking of RNA to nylon membranes improves the detection of siRNA, miRNA and piRNA by northern blot. Nucleic Acids Res., 35, e60